Yahoo Finance

Sirtex Medical's SIR-Spheres® Y-90 Resin Microspheres Receive FDA Approval for the Treatment of Unresectable Hepatocellular Carcinoma

Expanded indication makes SIR-Spheres ® the first and only radioembolization therapy in the U.S. approved to treat both unresectable hepatocellular carcinoma and metastatic colorectal cancer WOBURN, ...
News Medical

Study reveals promising results for primary liver cancer patients treated with SIR-Spheres Y-90 resin microspheres

Patients with advanced or inoperable Hepatocellular Carcinoma (HCC) who usually received one or two treatments with liver-directed SIR-Spheres Y-90 resin microspheres in the 459-patient French SARAH ...
Healio

FDA approves SIR-Spheres for unresectable hepatocellular carcinoma

Please provide your email address to receive an email when new articles are posted on . Y-90 resin microspheres are the only approved radioembolization therapy for hepatic cellular carcinoma and ...
Business Insider

New Analysis Reveals First-Line Treatment Data on SIR-Spheres® Y-90 Resin Microspheres for Patients with Liver Metastases from Right-Sided Primary Colon Cancer

SIRFLOX and FOXFIRE Global findings suggest that adding liver-directed Selective Internal Radiation Therapy (SIRT) to standard first-line chemotherapy may improve overall survival in metastatic ...
Pharmabiz

Radiation therapy SIR-Spheres to treat liver cancer launched in India

A revolutionary therapy called SIR-Spheres has been launched in India for the treatment of inoperable liver cancer. Dr Jakobs Tobias, associate professor of Radiology, Department of Radiology, Munich ...
Pharmabiz

Sirtex Medical’s SIR-Spheres Y-90 resin microspheres receive US FDA nod to treat unresectable hepatocellular carcinoma

Sirtex Medical (Sirtex), a leading manufacturer of interventional oncology solutions, announced that the US Food and Drug Administration (FDA) approved SIR-Spheres Y-90 resin microspheres for the ...